Impact Biomedical Inc. (ZOAR)

Last Closing Price: --

EBIT Margin (Quarterly)

EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues

Impact Biomedical Inc. (ZOAR) had EBIT Margin of -3085.71% for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$0.02M
$-0.65M
$0.01M
$0.01M
$0.67M
$-0.65M
$0.00M
$-0.64M
$-0.64M
$-0.64M
$-0.64M
$-0.64M
$-0.64M
$-0.65M
$-0.36M
8.54M
8.54M
$-0.08
$-0.08
Balance Sheet Financials
$0.10M
--
$16.32M
$16.43M
$2.37M
--
$0.69M
$3.06M
$13.37M
$-2.77M
$13.37M
8.54M
Cash Flow Statement Financials
$0.02M
$0.00M
--
$0.00M
$0.02M
$0.02M
$1.44M
--
--
Fundamental Metrics & Ratios
0.04
--
--
--
--
71.43%
-3085.71%
EBIT Margin
-3085.71%
--
-3066.67%
-3071.43%
$0.02M
--
--
--
0.00
0.11
--
--
-4.82%
23.22%
-3.92%
-4.82%
$1.56
$0.00
$0.00